Anti-glutamate transporter GLAST blocking peptide
Discontinued ProductUnfortunately Anti-glutamate transporter GLAST blocking peptide (Cat. No. 2129) has been withdrawn from sale for commercial reasons.
Synthetic peptide ([C]-QLIAQDNEPEKPVADSETKM) corresponding to C-terminal amino acids 524-543 of rat precursor glutamate transporter GLAST (Accession No. P24942) with a cysteine added at the N-terminus of the peptide. Immunogen used for anti-glutamate transporter GLAST (Cat. No. 2064).
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 2346.6. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||0.43 mL||2.13 mL||4.26 mL|
|5 mM||0.09 mL||0.43 mL||0.85 mL|
|10 mM||0.04 mL||0.21 mL||0.43 mL|
|50 mM||0.01 mL||0.04 mL||0.09 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Keywords: Blocking peptides anti-glutamate transporter GLAST EAAT Excitatory Amino Acid Transporters Monoamine Neurotransmitter immunogen Glutamate Transporters
Citations for Anti-glutamate transporter GLAST blocking peptide
Citations are publications that use Tocris products.
Currently there are no citations for Anti-glutamate transporter GLAST blocking peptide.
Literature in this Area
Huntington's Disease Poster
Huntington's disease (HD) is a monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the MSN intracellular signaling pathways implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.